812 related articles for article (PubMed ID: 24225968)
1. Translating genomics in cancer care.
Bombard Y; Bach PB; Offit K
J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
[TBL] [Abstract][Full Text] [Related]
2. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
Wilson BJ; Miller FA; Rousseau F
J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
[TBL] [Abstract][Full Text] [Related]
3. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
Bombard Y
Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
[No Abstract] [Full Text] [Related]
4. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
5. Genomic medicine and risk prediction across the disease spectrum.
Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
[TBL] [Abstract][Full Text] [Related]
6. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
7. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
[TBL] [Abstract][Full Text] [Related]
9. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
10. The impact of genomics on the future of medicine and health.
Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME
Med J Aust; 2014 Jul; 201(1):17-20. PubMed ID: 24999876
[No Abstract] [Full Text] [Related]
11. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
12. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
Surrey LF; Luo M; Chang F; Li MM
Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
[TBL] [Abstract][Full Text] [Related]
13. Multilevel research and the challenges of implementing genomic medicine.
Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
[TBL] [Abstract][Full Text] [Related]
14. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
15. Direct-to-consumer personal genome testing and cancer risk prediction.
Bellcross CA; Page PZ; Meaney-Delman D
Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric Genomics and Mental Health Treatment: Setting the Ethical Agenda.
Kong C; Dunn M; Parker M
Am J Bioeth; 2017 Apr; 17(4):3-12. PubMed ID: 28328372
[TBL] [Abstract][Full Text] [Related]
17. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
[TBL] [Abstract][Full Text] [Related]
18. [Ethical and social issues associated with genomic medicine].
Barazzetti G; Kaufmann A; Benaroyo L
Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
[TBL] [Abstract][Full Text] [Related]
19. Essential elements of personalized medicine.
Burke W; Brown Trinidad S; Press NA
Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
[TBL] [Abstract][Full Text] [Related]
20. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]